This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Leo-Pharma A/s. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jacob Thorhauge: Innovator in Pharmaceutical Chemistry
Introduction
Jacob Thorhauge is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Thorhauge holds a patent for "Hydroxamic acid esters and pharmaceutical use thereof." This invention relates to compounds of general formula I, which are designed for use—alone or in combination with other pharmaceutically active compounds—in therapy for treating diseases associated with deregulated angiogenesis, such as cancer. He has 1 patent to his name.
Career Highlights
Jacob Thorhauge is currently employed at Leo Pharma A/S, a company renowned for its focus on dermatology and critical care. His work at Leo Pharma has allowed him to explore innovative solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Thorhauge has collaborated with esteemed colleagues, including Jef Fensholdt and Bjarne Nørremark. These collaborations have further enriched his research and development efforts.
Conclusion
Jacob Thorhauge is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile